AstraZeneca and Janssen's Covid-19 vaccines are "
Read also: AstraZeneca vaccine: these health professionals who defy the advice of health authorities
We have no concerns about our ability to achieve our goals
" of 20 million people who received at least one dose in mid-May, then 30 million people in mid-June, "
and this, by integrating rather cautious assumptions on the level of consumption of AstraZeneca and Janssen
”, we assured the ministry during a weekly update on vaccines. On the other hand, according to the same source, "
if there is no more administration of AstraZeneca or if there is no administration of Janssen in town in the coming weeks, for once the objectives will be largely postponed. in question
The European Medicines Agency (EMA) is due to speak at the end of the afternoon on the Janssen vaccine (Johnson & Johnson), the use of which has been suspended in the United States and South Africa due to the rare onset of severe blood clots. This vaccine has been authorized since March 11 in the European Union, but has not yet been administered.
As for the vaccine from the Swedish-British laboratory AstraZeneca, some voices have questioned its continued use in view of the relative disaffection with which it is the subject, in particular in vaccination centers.
we do not wish to suggest that France could afford not to inject the AstraZeneca doses received.
In a context of a race against time against a virus that kills, we cannot afford to ignore the deployment of a vaccine that saves lives,
”insists the ministry.
Read also: Covid-19: the EU could not renew the contract with AstraZeneca, according to Thierry Breton
The EMA announced on April 7 that blood clots should be listed as a "
" side effect of this vaccine, while believing that the benefits outweigh the risks. Its use has been restricted in most EU countries (in France it is reserved for over 55s) and Denmark has announced that it is definitely giving up. If the slots reserved for AstraZeneca in vaccination centers are sometimes shunned, the flow in the city remains "
", with "
nearly 73% of use of the doses delivered
" last week, underlines the ministry.